Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.

被引：9

作者：

Albiges, Laurence

Negrier, Sylvie

Dalban, Cecile

Gravis, Gwenaelle

Chevreau, Christine

Oudard, Stephane

Laguerre, Brigitte

Barthelemy, Philippe

Borchiellini, Delphine

Gross-Goupil, Marine

Geoffrois, Lionnel

Brihoum, Meryem

Escudier, Bernard

机构：

[1] Univ Paris Sud, Gustave Roussy Inst Oncol, Villejuif, France

[2] Ctr Leon Berard, Lyon, France

[3] Inst Paoli Calmettes, Marseille, France

[4] IUCT Oncopole Inst Claudius Regaud, Toulouse, France

[5] AP HP, Hop Europeen Georges Pompidou, Paris, France

[6] Ctr Eugene Marquis, Rennes, France

[7] Hopitaux Univ Strasbourg, Strasbourg, France

[8] Ctr Antoine Lacassagne, Nice, France

[9] Ctr Hosp Univ St Andre, Bordeaux, France

[10] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France

[11] UNICANCER, Paris, France

[12] Gustave Roussy Canc Campus, Villejuif, France

来源：

关键词：

D O I：

10.1200/JCO.2018.36.6_suppl.577

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

577

引用

页数：1